Here are four notes:
1. NuVasive posted earnings per share of $0.35 for the third quarter of 2015.
2. Analysts have a consensus price target of $60.50 on NuVasive shares.
3. The shares have a broker recommendation of 1.53.
4. Three months ago, the stock also had a rating of 1.53.
More articles on devices:
Geisinger Health to pilot wearable technology tracking program: 5 points
Stryker acquires Sage Products for $2.7B — 5 takeaways
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
